The Turner Syndrome Foundation is proud to announce its involvement in the Network for Advancing Sex Chromosome Aneuploidy Research Readiness (NASCARR), a newly funded initiative through the Rare Diseases Clinical Research Network (RDCRN).
This partnership represents an important step forward in advancing research, collaboration, and long-term progress for individuals with Turner syndrome and the broader sex chromosome aneuploidy (SCA) community.
What Are NASCARR and RDCRN?
As we begin sharing more about this initiative, become familiar with some of the terms and organizations involved.
RDCRN: Rare Diseases Clinical Research Network
The Rare Diseases Clinical Research Network (RDCRN) is an NIH-funded network made up of 21 active research consortia or research groups focused on rare diseases. The network supports collaborative research among scientists, clinicians, patient advocacy organizations, and communities to better understand rare conditions and improve approaches to diagnosis, treatment, and care.
The RDCRN exists to:
- Advance scientific understanding of rare diseases
- Improve clinical research readiness
- Foster collaboration across institutions and specialties
- Develop better pathways for diagnosis, care, and future treatments
NASCARR: Network for Advancing Sex Chromosome Aneuploidy Research Readiness
NASCARR is one of the newly funded RDCRN research consortia. Its focus is on sex chromosome aneuploidies (SCAs), a group of genetic conditions caused by differences in the number of sex chromosomes. This includes Turner syndrome, along with several other conditions.
The recent funding of NASCARR is a major milestone for research in this space, creating opportunities for stronger collaboration, expanded data collection, improved research infrastructure, and greater long-term readiness for future clinical studies.
Why This Matters for the Turner Syndrome Community
Research is one of the core pillars of the Turner Syndrome Foundation’s mission. Our involvement in NASCARR reflects our commitment to helping move research forward that can shape the future of care.
Patient advocacy organizations play an important role within the RDCRN model. Rather than existing separately from the research process, advocacy groups are integrated into the network to help ensure that patient voices, lived experiences, and community priorities remain part of the conversation.
As part of NASCARR:
- TSF will participate in ongoing consortium meetings and collaborative discussions
- The Turner syndrome community will have representation within a national research network
- Community perspectives can help inform research priorities and outreach efforts
This partnership will help strengthen connections between researchers, clinicians, advocacy organizations, and individuals living with rare conditions.
Looking Ahead
Right now, NASCARR is in its early stages, and much of the infrastructure is still being developed. In the coming months, we’ll continue sharing updates to help our community stay up-to-date with this initiative.
This is just the beginning, and we are excited about what this collaboration could mean for the future of Turner syndrome research.
Discover more from Turner Syndrome Foundation
Subscribe to get the latest posts sent to your email.
